When comparing CE+ and CE- patients (Fig. 4), the two different isoforms of Orai1 were increased (P = 0.04), and, although not significant, there is a trend for higher TRPC1 expression in CE+ B-CLL cells compared to CE- B-CLL cells. Here, ORAI1 is linked to B-cell chronic lymphocytic leukemia.